Akari Therapeutics (AKTX) Free Cash Flow (2014 - 2025)
Akari Therapeutics (AKTX) free cash flow from Mar 31, 2014 to Sep 30, 2025. The TTM Akari Therapeutics (AKTX) free cash flow is -$9.65M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Akari Therapeutics (AKTX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +42.28% |
| 3 Years | -34.31% |
| 5 Years | -22.29% |
| All Time | +0.29% |
Annual Free Cash Flow change of Akari Therapeutics (AKTX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$7.53M | -40.00% |
| 2024 | -$13M | -23.62% |
| 2023 | -$16M | -23.58% |
| 2022 | -$22M | +14.06% |
| 2021 | -$19M | +11.21% |
| 2020 | -$17M | +31.19% |
| 2019 | -$13M | -42.78% |
| 2018 | -$23M | -28.63% |
| 2017 | -$32M | +322.99% |
| 2016 | -$7.48M | +50.20% |
| 2015 | -$4.98M | +236.49% |
| 2014 | -$1.48M | -90.87% |
| 2013 | -$16M | +50.65% |
| 2012 | -$11M | +965.35% |
| 2011 | -$1.01M | +172.97% |
| 2010 | -$370K | N/A |